Skip to content

CG Oncology CGON Market capitalization

Market capitalization at other companies

Pfizer logo
PfizerPFE
$159.73B+11.1%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$588.76B+47.3%
Gilead Sciences logo
Gilead SciencesGILD
$172.99B+23.8%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$7.92B+208%
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
$6.25B+816%
Tango Therapeutics logo
Tango TherapeuticsTNGX
$2.99B+1,915%

Other financials

Income statement

See full
Revenue$1.1M+1,983%
Operating income-$66.4M-57.3%
Net income-$60.2M-74.7%
EPS (diluted)-$0.71-57.8%

Balance sheet

See full
Cash & equivalents$33.7M-18.7%
Total debt$7.6M+631%
Total equity$1.1B+54.9%
Total assets$1.1B+55.9%

Cash flow

See full
Operating cash flow-$56.9M-94.5%
CapEx$304.0K+1,800%
Free cash flow-$57.2M-95.4%

Profitability

See full
Operating margin-4,239%-1,872pp
Net margin-3,682.6%-1,601pp
FCF margin-3,163.8%-1,351pp

Returns & leverage

See full
Return on equity-20.8%+7.1pp
Debt / equity0.0×
Current ratio31.3×+0.3×

Where this comes from

Computed from the period-end share price: $5.71B.

The official record: CG Oncology’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about CG Oncology's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CG Oncology's market capitalization?
CG Oncology (CGON) reported market capitalization of $5.71B in Q1 2026.
How has CG Oncology's market capitalization changed year-over-year?
CG Oncology's market capitalization increased by 206.2% year-over-year, from $1.87B to $5.71B.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.